about
The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effectsArachnoServer 2.0, an updated online resource for spider toxin sequences and structuresTRP channels in neurogastroenterology: opportunities for therapeutic interventionAllostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapesAntagonists show GTP-sensitive high-affinity binding to the sigma-1 receptorNonsynaptic communication through ATP release from volume-activated anion channels in axonsmGluR1/TRPC3-mediated Synaptic Transmission and Calcium Signaling in Mammalian Central Neurons.Nav1.7 and other voltage-gated sodium channels as drug targets for pain reliefPhytocannabinoids beyond the Cannabis plant - do they exist?International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ChEMBL: a large-scale bioactivity database for drug discoveryStable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonistsNatriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide14-Deoxyandrographolide desensitizes hepatocytes to tumour necrosis factor-alpha-induced apoptosis through calcium-dependent tumour necrosis factor receptor superfamily member 1A release via the NO/cGMP pathwayAdenosine and inosine release during hypoxia in the isolated spinal cord of neonatal ratsEnhancement of mesenteric artery contraction to 5-HT depends on Rho kinase and Src kinase pathways in the ob/ob mouse model of type 2 diabetesThe phospholipase C inhibitor U-73122 inhibits Ca2+ release from the intracellular sarcoplasmic reticulum Ca2+ store by inhibiting Ca2+ pumps in smooth muscleMonoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cellsInvolvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation.Teneurin C-terminal associated peptide-1 blocks the effects of corticotropin-releasing factor on reinstatement of cocaine seeking and on cocaine-induced behavioural sensitization.Augurin stimulates the hypothalamo-pituitary-adrenal axis via the release of corticotrophin-releasing factor in ratsEndocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex.Simultaneous detection of intracellular target and off-target binding of small molecule cancer drugs at nanomolar concentrations.Ca2+ paradox injury mediated through TRPC channels in mouse ventricular myocytes.Cis-isomerism and other chemical requirements of steroidal agonists and partial agonists acting at TRPM3 channelsNew horizons in the treatment of cystic fibrosis.The anti-protozoal drug pentamidine blocks KIR2.x-mediated inward rectifier current by entering the cytoplasmic pore region of the channel.Functional neurokinin and NMDA receptor activity in an animal naturally lacking substance P: the naked mole-ratPredicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers.Caspase-3 knock-down reverses contractile dysfunction induced by sepsis in adult rat ventricular myocytesExpression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes.Structurally diverse amphiphiles exhibit biphasic modulation of GABAA receptors: similarities and differences with neurosteroid actions.Bisphenol A activates Maxi-K (K(Ca)1.1) channels in coronary smooth muscleChallenges for and current status of research into positive modulators of AMPA receptors.Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosol-independent action at reperfusion.The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptideIncreased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5.Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.Disruption of cellular cholesterol transport and homeostasis as a novel mechanism of action of membrane-targeted alkylphospholipid analogues.
P2860
Q24596842-9CAB1C88-8969-43D3-88EB-88A6B43A1980Q24606148-ED04AF87-DF4B-4DAD-9589-A559C59E63ADQ24615380-94F7DF2F-53A3-4641-BA70-D39EB5B717FAQ24618774-F938AA33-68F5-4F17-88EB-E8458AB18BE3Q24633877-83751923-D8F7-463F-A358-3AA75BAB810CQ24635201-CFDAE47E-0C39-4DBA-8F7A-5B84CCABB9A6Q27329978-149788B9-14B1-4CD1-86F8-D5207EFDED15Q27691381-7544091E-20B3-4F17-8722-E465A27DDAAFQ28273870-70F7A74A-D445-45DC-8006-7A374FD050A9Q28286497-B4296BA5-E2F7-4FEB-B110-6BCBFC46BBBDQ28298445-50F1C9D7-4043-4D41-9944-8BF8C8726CD5Q28315179-2B4555A3-83B4-4841-8888-DE0CD3F96183Q28388268-A31BAEBD-907D-4D2C-9F2F-691FBD9F499FQ28570682-A79B7A2B-85A1-4DF0-85CE-2D92403C7940Q28573528-4EEE19D7-80DB-473E-B111-04AE2659F3C8Q28573737-19B6672D-3F1D-421C-930B-D83D97A48F0AQ28749389-6E919CD0-07D1-4D60-A966-20C10EAF5770Q28972365-6D919618-80B4-47CE-A6A6-1A260A498972Q30048609-B5E0C1D4-1D91-42DE-801D-5453FAE39884Q30470845-4625EC55-3A83-49BA-923B-D27855EB242DQ30470848-F942A5C9-6CCC-47BD-AF92-09004BA025BDQ30968576-0168320D-A811-4632-8D5D-AEDA4401C766Q33621756-8E659DCC-D428-4908-B588-C8A436B35668Q33621763-31169FE6-C022-4E52-95E4-4A556A55FD50Q33662444-F68C7AC9-EB0A-4628-91B4-FB1C414FD17BQ33671205-1A6E6F1E-DDBD-4FA9-A721-0EDEB67C0C11Q33756002-7BC975DA-B15B-454B-A10A-9350384E7612Q33772899-D1FC25FA-7B0F-4872-BF84-44B0D50D2B60Q33784210-A39FFB7F-BA71-41FA-99BA-1CEDEC418F19Q33812750-A7C6642B-7BCC-4AE2-B0A6-3444DBE5D222Q33812768-5287DE15-1932-42A5-AE7D-C30D4B021337Q33812773-FC2E336D-29F3-4E84-9B9B-505DF4C623D6Q33812781-D541CF32-E06A-40F8-92A7-B7CF3B8F7932Q33812793-43EAD524-EB41-47A2-931C-A78704383CB8Q33870362-EA615B76-CBED-4674-B12F-EF0D5F1E157DQ33870380-BA0B3BC0-FB54-4D5A-A47C-555197DAC648Q33870388-98DEC258-B0FF-4978-BF90-ED9BFCB94634Q33870421-532887A2-563D-4E18-A597-4DC2B4FE0DE1Q33870433-04C209A0-D33C-488C-A159-681C84159F94Q33870440-C5257F4F-E3FE-41AC-9291-E4C7EBF33264
P2860
description
im November 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2009
@uk
name
Guide to Receptors and Channels (GRAC), 4th Edition
@en
Guide to Receptors and Channels (GRAC), 4th Edition
@nl
type
label
Guide to Receptors and Channels (GRAC), 4th Edition
@en
Guide to Receptors and Channels (GRAC), 4th Edition
@nl
prefLabel
Guide to Receptors and Channels (GRAC), 4th Edition
@en
Guide to Receptors and Channels (GRAC), 4th Edition
@nl
P1476
Guide to Receptors and Channels (GRAC), 4th Edition
@en
P2860
P304
P356
10.1111/J.1476-5381.2009.00499.X
P407
P478
158 Suppl 1
P577
2009-11-01T00:00:00Z